AKTX
Akari Therapeutics plc ADR (0.01 USD)
PHARMACEUTICAL PREPARATIONS
Best Pharmaceutical Stocks 2026 →
AKTX Stock Analysis: Buy, Sell, or Hold?
$7.49
+0.36 (+4.98%)
▲
5d:
-19.43%
30d:
-5.25%
90d:
+6.93%
Open in Live Scanner
70/30 Portfolio Builder
Earnings: Nov 12, 2026
TODAY
Updated Nov 10, 12:00 AM ET
QUANTITATIVE VERDICT
WAIT
LOW Confidence (63%)
Quality Score
36/100
Position
OVERSOLD
30-Day Fair Range
$7.63 – $8.96
Position: OVERSOLD
Forward P/E & Valuation
-0.8x
Next 12M consensus est.
Wall Street Target
$25.50
+257.6% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$6.91 / $9.83
Trend: Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
⏸️ WAIT FOR STABILIZATION: AKTX is down 19.4% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
Get Alerted When AKTX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: AKTX is currently trading at $7.49, which is considered oversold relative to its 30-day fair value range of $7.63 to $8.96.
Technical Outlook: Technically, AKTX is in a downtrend. Immediate support is located at $6.91, while resistance sits at $9.83. The stock is showing strong short-term momentum, up 5.0% recently.
Market Sentiment: AKTX scores 30/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $25.50 (+257.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, AKTX is in a downtrend. Immediate support is located at $6.91, while resistance sits at $9.83. The stock is showing strong short-term momentum, up 5.0% recently.
Market Sentiment: AKTX scores 30/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $25.50 (+257.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$7.63 -
$8.96
Company Quality Score
36/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
63.2%
Trading Range & Key Levels
30-Day Trading Range
$7.63 -
$8.96
Current vs Trading Range
OVERSOLD
Support Level
$6.91
Resistance Level
$9.83
Current Trend
Downtrend
Technical data as of
Nov 10, 2026
Quantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (30/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+5.0%)
- BULLISH: Trading 257.6% below Wall St target ($25.50)
- WARNING: Composite score 36/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-0.82
Wall Street Target
$25.50
(+257.6%)
Share AKTX Analysis
Share this live AKTX analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.
Last updated: November 11, 2026 1:25 PM ET
Data refreshes hourly during market hours. Next update: 2:25 PM
Data refreshes hourly during market hours. Next update: 2:25 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is AKTX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
REGN
Regeneron Pharmaceutical… |
BUY
28 analysts |
$978 | 35 SELL |
|
PRAX
Praxis Precision Medicin… |
STRONG BUY
21 analysts |
$650 | 38 SELL |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
22 analysts |
$296 | 31 SELL |
|
NAMS
NewAmsterdam Pharma Comp… |
STRONG BUY
16 analysts |
$50 | 44 HOLD |
|
ACAD
ACADIA Pharmaceuticals I… |
STRONG BUY
20 analysts |
$31 | 43 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive AKTX Research Pages
